Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.080 | 0.625 | 8 | 2009 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.080 | 0.625 | 8 | 2009 | 2019 | ||||
Carcinoma of lung
|
1204 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.060 | 1.000 | 6 | 2005 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.060 | 1.000 | 6 | 2005 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.060 | 1.000 | 6 | 2005 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.050 | 0.600 | 5 | 2005 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.050 | 0.600 | 5 | 2005 | 2019 | ||||
Malignant neoplasm of prostate
|
1082 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.040 | 0.750 | 4 | 2006 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.040 | 0.750 | 4 | 2006 | 2019 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.030 | 1.000 | 3 | 2006 | 2012 | ||||
Bladder Neoplasm
|
281 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Cancer of Urinary Tract
|
11 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Carcinoma of bladder
|
309 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2011 | 2015 | ||||
Liver carcinoma
|
942 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Acute lymphocytic leukemia
|
222 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Adult Hodgkin Lymphoma
|
27 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Adult Meningioma
|
30 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Cancer of Digestive System
|
15 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Carcinoma of larynx
|
65 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Carcinoma, Basal Cell
|
91 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
cervical cancer
|
268 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Cervix carcinoma
|
283 | 0.605 | 0.600 | 8 | 89978251 | missense variant | C/G | snv | 0.35 | 0.31 | 0.010 | 1.000 | 1 | 2009 | 2009 |